Ben Izar's lab is a pioneer in combining single cell techniques, genome-editing, and systems biology to explore the cancer field’s most pressing problems.
Including BRCA1 testing with prenatal carrier screening could identify people at risk of breast, ovarian, and pancreatic cancer at a time when cancer screening could save their lives.
A study from Columbia researchers suggests that changing a single letter in the DNA code of selected genes in T cells may supercharge cell therapies against cancer.
A Columbia study may lead to stomach cancer screening guidelines, especially for Black and Hispanic Americans who have a greater risk of developing or dying from stomach cancer than white Americans.
Columbia University's chief of breast imaging, Elise Desperito, MD, clarifies conflicting advice on mammography and urges all women to be evaluated for their breast cancer risk.
Columbia breast cancer patient Karin Diamond credits regular mammograms for catching her cancer early and her surgeon's use of intraoperative radiation for keeping her cancer-free.
Overall survival for breast cancer has improved by about 40% since the 1980s. Precision medicine and new screening tests may lead to even better outcomes in the future.
The 2021 edition of Velocity raised $1.1 million to support cancer research and care at Columbia University's Herbert Irving Comprehensive Cancer Center.
Despite clinical guidelines that advocate surgery as a first step, a Columbia study suggests many patients with advanced ovarian cancer should be treated with chemotherapy before surgery.
Just 17 when diagnosed with advanced cervical cancer, Sheneque Hanse is now in remission after two years of treatment and eager to start a career in health care to help others with cancer.